Decheng Capital China Life Sciences USD Fund III, L.P. sold $41k of BYSI
owner at BeyondSpring Inc.. 21,046 shares at an average of $1.94, traded Sep 9, 2025, filed Sep 11, 2025.
Score components
- +12Role10% owner
- +6Trade size$41k at market
- 0Share of holdings soldSold 1.1% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -7.0%, 3m +16.6%, 6m -12.8%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001415889-25-024317, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Sep 9, 2025 | SOpen-market sale Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P. | -9,050 | $1.97 | $18k | 1,886,706 | Sep 11, 2025 |
| Sep 10, 2025 | SOpen-market sale Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P. | -8,176 | $1.93 | $16k | 1,878,530 | Sep 11, 2025 |
| Sep 11, 2025 | SOpen-market sale Ordinary Sharesindirect: By Decheng Capital China Life Sciences USD Fund III, L.P. | -3,820 | $1.90 | $7,258 | 1,874,710 | Sep 11, 2025 |
Related signals
Other insiders at BeyondSpring Inc. and this insider’s other filings.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.